How can AI help companies looking for vaccines? - Marketplace

The new coronavirus is now officially a pandemic, and researchers are speeding to discover, test and deploy a vaccine. Some are hoping that breakthrough biotechnology and artificial intelligence can get us there faster. Much of the funding and development of a COVID-19 vaccine is likely to happen privately. The $8 billion coronavirus funding bill passed by the U.S. government includes just $800 million for the National Institutes of Health, where official U.S. vaccine research and development happens, but which is chronically underfunded. I asked Michael Greeley, co-founder and general partner with biotech investment fund Flare Capital in Boston, what uses AI could have in dealing with coronavirus.